Summary of Significant Accounting Policies - Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net Income Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Numerator:
Net Income (Loss)		$ 4,461	$ 41,609	$ 949
Basic:
Weighted average shares of common stock and vested, undelivered restricted stock units outstanding		28,327,591	29,589,000	28,434,213
Diluted:
Weighted average shares of common stock and vested, undelivered restricted stock units outstanding		28,327,591	29,589,000	28,434,213
Effect of potentially dilutive shares		166,953	4,483,131	1,039,678
Total weighted average shares of common stock and vested, undelivered restricted stock units outstanding and potentially dilutive shares		28,494,544	34,072,131	29,473,891
Basic:
Net income applicable to common stockholders		$ 4,461	$ 41,609	$ 949
Weighted average shares of stock outstanding		28,327,591	29,589,000	28,434,213
Net income per common share		$ 0.16	$ 1.41	$ 0.03
Diluted:
Net income applicable to common stockholders	[1]	$ 4,461	$ 44,173	$ 949
Weighted average shares of stock outstanding		28,494,544	34,072,131	29,473,891
Net income per common share	[2]	$ 0.16	$ 1.3	$ 0.03

[1] For the year ended December 31, 2022, we excluded $2.6 million of amortization and interest expense relating to our convertible notes when calculating net income for diluted earnings per share. There was no such adjustment in 2023 or 2021, due to anti-dilutive nature of the add-back.

[2] In calculating diluted net income per share, 1.3 million shares, 107 thousand shares, and 14 thousand shares related to outstanding stock options and unvested, undelivered restricted stock units which were excluded for the years ended December 31, 2023, 2022, and 2021, respectively, because they were anti-dilutive. Additionally, in calculating diluted net income per share, weighted average shares includes 3.9 million shares related to the if converted basis of our convertible notes for the year ended December 31, 2022. There was no such adjustment for 2023 or 2021 due to the anti-dilutive nature of the add-back.